Revisiting the impacts of silica nanoparticles on endothelial cell junctions and tumor metastasis

[1]  Yang Liu,et al.  Advanced bioactive nanomaterials for biomedical applications , 2021, Exploration.

[2]  Wolfgang J. Parak,et al.  Nanotoxicology and Nanomedicine: The Yin and Yang of Nano-Bio Interactions for the New Decade. , 2021, Nano today.

[3]  Heliang Yao,et al.  Intratumoral synthesis of nano-metalchelate for tumor catalytic therapy by ligand field-enhanced coordination , 2021, Nature Communications.

[4]  Jianlin Shi,et al.  Nanocatalytic Innate Immunity Activation by Mitochondrial DNA Oxidative Damage for Tumor‐Specific Therapy , 2021, Advanced materials.

[5]  Kimberly S. Butler,et al.  Synthetic amorphous silica nanoparticles: toxicity, biomedical and environmental implications , 2020, Nature Reviews Materials.

[6]  P. Timpson,et al.  Fluids and their mechanics in tumour transit: shaping metastasis , 2019, Nature Reviews Cancer.

[7]  Jianlin Shi,et al.  Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition. , 2019, Journal of the American Chemical Society.

[8]  Yu Chen,et al.  Mesoporous silica/organosilica nanoparticles: Synthesis, biological effect and biomedical application , 2019, Materials Science and Engineering: R: Reports.

[9]  Ying Liu,et al.  Long-term pulmonary exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades , 2019, Nature Nanotechnology.

[10]  M. I. Setyawati,et al.  Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness , 2019, Nature Nanotechnology.

[11]  Han Lin,et al.  Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy. , 2018, Chemical Society reviews.

[12]  Xiaoyuan Chen,et al.  Rethinking cancer nanotheranostics. , 2017, Nature reviews. Materials.

[13]  Seung-Min Park,et al.  Towards clinically translatable in vivo nanodiagnostics. , 2017, Nature reviews. Materials.

[14]  Chor Yong Tay,et al.  Gold Nanoparticles Induced Endothelial Leakiness Depends on Particle Size and Endothelial Cell Origin. , 2017, ACS nano.

[15]  K. Thurecht,et al.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date , 2016, Pharmaceutical Research.

[16]  Mengli Li,et al.  Large Pore‐Sized Hollow Mesoporous Organosilica for Redox‐Responsive Gene Delivery and Synergistic Cancer Chemotherapy , 2016, Advanced materials.

[17]  M. I. Setyawati,et al.  Tuning Endothelial Permeability with Functionalized Nanodiamonds. , 2016, ACS nano.

[18]  Chor Yong Tay,et al.  Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood. , 2015, Chemical Society reviews.

[19]  Say Chye Joachim Loo,et al.  Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE–cadherin , 2013, Nature Communications.

[20]  Mingjie Zhu,et al.  Targeted doxorubicin delivery to liver cancer cells by PEGylated mesoporous silica nanoparticles with a pH-dependent release profile , 2012 .

[21]  Linlin Li,et al.  Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery , 2012, Advanced materials.

[22]  Alexander M. Seifalian,et al.  Toxicology and clinical potential of nanoparticles , 2011, Nano today.

[23]  Taeghwan Hyeon,et al.  Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. , 2011, Accounts of chemical research.

[24]  Yasuo Yoshioka,et al.  Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. , 2011, Nature nanotechnology.

[25]  Mark B. Carter,et al.  The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers , 2011, Nature materials.

[26]  Suntharampillai Thevuthasan,et al.  PEGylated inorganic nanoparticles. , 2011, Angewandte Chemie.

[27]  Yu Chen,et al.  Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands , 2011 .

[28]  Jianlin Shi,et al.  The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. , 2010, Biomaterials.

[29]  V. Gewin.  Big opportunities in a small world. , 2009, Nature.

[30]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[31]  Brian G. Trewyn,et al.  Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications , 2007 .

[32]  Yufang Zhu,et al.  Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. , 2005, Angewandte Chemie.

[33]  Victor S-Y Lin,et al.  Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. , 2005, Angewandte Chemie.

[34]  Victor S-Y Lin,et al.  A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. , 2004, Journal of the American Chemical Society.

[35]  Masahiro Fujiwara,et al.  Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica , 2003, Nature.

[36]  Jianlin Shi,et al.  MSN Anti‐Cancer Nanomedicines: Chemotherapy Enhancement, Overcoming of Drug Resistance, and Metastasis Inhibition , 2014, Advanced materials.

[37]  R. Service.  American Chemical Society Spring Meeting. Nanoparticles offer 'open sesame' keys to new drugs and vaccines. , 2012, Science.